Robbie Majzner MD

PubMed

• New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysis.
  Andrew D J Pearson, Claudia Rossig, Crystal L Mackall, Nirali N Shah, André Baruchel
  The Lancet. Oncology. 2025-04-01
• 6 citations
  Intravenous and intracranial GD2-CAR T cells for H3K27Mdiffuse midline gliomas.
  Michelle Monje, Jasia Mahdi, Robbie Majzner, Kristen W Yeom, Liora M Schultz
  Nature. 2025-01-01
• 1 citations
  Author Correction: Intravenous and intracranial GD2-CAR T cells for H3K27Mdiffuse midline gliomas.
  Michelle Monje, Jasia Mahdi, Robbie Majzner, Kristen W Yeom, Liora M Schultz
  Nature. 2024-12-01

Journal Articles

• Tumor Antigen Escape from CAR T-cell Therapy  
  Crystal L Mackall, Robbie G Majzner, Clinical Cancer Research

Abstracts/Posters

• Identification of Dual Positive CD19+/CD3+ T Cells in an Apheresis Product Undergoing Chimeric Antigen Receptor (CAR) Transduction
  Robbie G. Majzner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Phase I Trial Using CD19/CD22 Bispecific CAR T Cells in Pediatric and Adult Acute Lymphoblastic Leukemia (ALL)
  Robbie G. Majzner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• CAR T Cell Therapy for Neuroblastoma
  Robbie Majzner, MD, Frontiers in Neurology, Orlando, FL, 12/9/2019